The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
The USFDA has determined the inspection classification status of this warehousing facility as 'Official Action Indicated
the inspection conducted from January 27 to January 31, 2025
Observations are largely around improvement of procedures and practices
_256_384.jpg)
Hikal Limited announces the completion of the US Food and Drug Administration (USFDA) inspection at its Jigani unit, Bengaluru
Our Q3 FY25 revenue was at Rs. 1,384.1 crore with an EBITDA of Rs. 360 crore resulting in a 26% EBITDA margin
OneSource operates five cGMP facilities and has a strong track record, with 138 successful regulatory and customer audits to date by all major regulatory bodies
_256_384.jpg)
Mesalazine is used to treat inflammatory bowel disease
Biocon Biologics remains committed to global standards of quality and compliance
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
Subscribe To Our Newsletter & Stay Updated
